The review summarizes both biological and non-biological transformation methods that enable the precise introduction of beneficial genes into plants. It also outlines recent breakthroughs that improve ...
In a report released on August 7, Puneet Souda from Leerink Partners maintained a Buy rating on Myriad Genetics (MYGN – Research Report), with a price target of $35.00. Puneet Souda has given his Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results